Get the Stockscreener App
0.7095
4.70%
-0.035
After Hours:
.71
0.0005
+0.07%
Vivos Therapeutics Inc Stock (VVOS) Forecast
The Vivos Therapeutics Inc (VVOS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.5393, representing a +257.90% increase from the current price of $0.7095. The highest analyst price target is $2.5215, and the lowest is $2.5571.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VVOS Price Target
Average 2.2188
(+212.72% Upside)
Is Vivos Therapeutics Inc (VVOS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 29.24 | Buy |
| STOCH(9,6) | 8.1176 | Buy |
| STOCHRSI(14) | 6.5494 | Buy |
| MACD(12,26) | -0.1391 | Sell |
| ADX(14) | 17.38 | Neutral |
| William %R | -96.78 | Buy |
| CCI(14) | -58.98 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8325
Sell
|
0.8395
Sell
|
| MA20 |
1.0019
Sell
|
0.952
Sell
|
| MA50 |
1.1815
Sell
|
1.1845
Sell
|
| MA100 |
1.5359
Sell
|
1.5497
Sell
|
| MA200 |
2.4907
Sell
|
2.1008
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VVOS could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on VVOS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 29.24 indicates that VVOS is oversold. This indicates that VVOS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 8.1176 indicates that VVOS is oversold. This indicates that VVOS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.5494 indicates that VVOS is oversold. This suggests that VVOS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.38 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -58.98 indicates that VVOS is still oversold but not to an extreme extent.
Long-term VVOS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vivos Therapeutics Inc financial reports and earnings history, Vivos Therapeutics Inc (VVOS) stock could reach $5.6446 by 2030, $16.10 by 2040 and $18.92 by 2050. See the projected annual prices until 2050 of the Vivos Therapeutics Inc stock below:
- Vivos Therapeutics Inc (VVOS) is expected to reach an average price of $6.9246 in 2035, with a high prediction of $7.0231 and a low estimate of $6.9348. This indicates an $875.98% rise from the last recorded price of $0.7095.
- Vivos Therapeutics Inc (VVOS) stock is projected to chart a bullish course in 2040, with an average price target of $17.15, representing an $2,317% surge from its current level. The forecast ranges from a conservative $16.19 to a sky-high $16.10.
- Our analysts predict Vivos Therapeutics Inc (VVOS) to jump 2,886% by 2045, soaring from $21.04 to an average price of $21.18, potentially reaching $20.90. While $21.04 is the low estimate, the potential upside is significant.
- Vivos Therapeutics Inc (VVOS) stock is expected to climb by 2050, reaching an average of $18.54, a $2,513% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.92 and $18.62, respectively, highlighting the market's uncertainty.
Vivos Therapeutics Inc Stock (VVOS) Year by Year Forecast
Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2026
The predicted value for Vivos Therapeutics Inc (VVOS) in 2026 is set at an average of $2.2188. Estimates vary from a peak of $2.7384 to a trough of $1.6991, indicating an +212.72% surge from the present price of $0.7095.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $2.6424 | $2.5571 | $2.5215 | +272.43% |
| July, 2026 | $2.7987 | $2.6442 | $2.6735 | +294.46% |
| August, 2026 | $1.5565 | $2.6365 | $2.7384 | +119.37% |
| September, 2026 | $1.8198 | $1.6991 | $1.6998 | +156.49% |
| October, 2026 | $2.3205 | $2.0735 | $2.2315 | +227.06% |
| November, 2026 | $2.5171 | $2.5372 | $2.4912 | +254.77% |
| December, 2026 | $2.4305 | $2.4545 | $2.4696 | +242.57% |
Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vivos Therapeutics Inc (VVOS) is $23.57, with a high forecast of $46.62 and a low forecast of $0.52. This indicates an +3,222% increase from the last price of $0.7095.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.3052 | $2.3852 | $2.3898 | +224.90% |
| February, 2027 | $2.1359 | $2.2159 | $2.2779 | +201.04% |
| March, 2027 | $2.2592 | $2.0963 | $2.1692 | +218.43% |
| April, 2027 | $2.1304 | $2.2172 | $2.2147 | +200.27% |
| May, 2027 | $2.1546 | $2.1606 | $2.1569 | +203.68% |
| June, 2027 | $2.0459 | $2.1438 | $2.1185 | +188.36% |
| July, 2027 | $0.9554 | $0.8139 | $2.748 | +34.65% |
| August, 2027 | $2.3047 | $0.52 | $2.8047 | +224.83% |
| September, 2027 | $9.2313 | $1.902 | $46.62 | +1,201% |
| October, 2027 | $4.4707 | $4.4707 | $10.75 | +530.11% |
| November, 2027 | $3.33 | $2.9401 | $7.1444 | +369.34% |
| December, 2027 | $2.9566 | $2.8246 | $4.322 | +316.72% |
Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2028
In 2028, Vivos Therapeutics Inc (VVOS) is projected to reach an average price of $3.3211, with a high projection of $6.0289 and a low estimate of $0.6133. This indicates an +368.09% rise from the last price of $0.7095.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2059 | $1.1359 | $3.4013 | +69.97% |
| February, 2028 | $0.7953 | $0.6133 | $1.6533 | +12.09% |
| March, 2028 | $3.998 | $0.7326 | $3.778 | +463.50% |
| April, 2028 | $3.0394 | $3.5093 | $2.974 | +328.38% |
| May, 2028 | $2.4761 | $2.7354 | $2.4171 | +248.99% |
| June, 2028 | $2.4275 | $2.8975 | $2.5337 | +242.14% |
| July, 2028 | $2.6888 | $1.5728 | $1.6388 | +278.97% |
| August, 2028 | $4.3155 | $3.6695 | $3.9855 | +508.25% |
| September, 2028 | $4.3769 | $4.3509 | $4.2769 | +516.90% |
| October, 2028 | $5.2182 | $4.8022 | $5.0382 | +635.48% |
| November, 2028 | $3.735 | $4.2881 | $6.0289 | +426.42% |
| December, 2028 | $4.1863 | $3.9356 | $3.6456 | +490.04% |
Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2029
The 2029 price forecast for Vivos Therapeutics Inc Stock (VVOS) is $5.3897 on average, with a high prediction of $6.0578 and a low estimate of $4.7217. This represents an +659.65% increase from the previous price of $0.7095.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.083 | $4.7217 | $4.8618 | +616.42% |
| February, 2029 | $4.6344 | $4.8944 | $4.8837 | +553.19% |
| March, 2029 | $6.1357 | $5.8092 | $5.7604 | +764.80% |
| April, 2029 | $6.0371 | $5.8763 | $5.5471 | +750.90% |
| May, 2029 | $5.6438 | $5.7238 | $6.0578 | +695.46% |
| June, 2029 | $4.7052 | $5.3752 | $5.4465 | +563.17% |
| July, 2029 | $5.0865 | $4.7267 | $4.8765 | +616.92% |
| August, 2029 | $5.7032 | $5.3372 | $5.5908 | +703.84% |
| September, 2029 | $6.1346 | $5.9193 | $5.6939 | +764.64% |
| October, 2029 | $5.8413 | $5.5806 | $5.8899 | +723.30% |
| November, 2029 | $5.9927 | $5.992 | $5.9327 | +744.63% |
| December, 2029 | $5.924 | $5.7334 | $5.698 | +734.96% |
Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2030
Vivos Therapeutics Inc Stock (VVOS) is expected to reach an average price of $5.3337 in 2030, with a high forecast of $5.9139 and a low forecast of $4.7536. This signifies an +651.76% surge from the last price of $0.7095.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.6707 | $5.6907 | $5.6446 | +699.26% |
| February, 2030 | $5.9343 | $5.6914 | $5.6122 | +736.41% |
| March, 2030 | $5.8435 | $5.9634 | $5.9139 | +723.60% |
| April, 2030 | $5.8848 | $5.8342 | $5.7842 | +729.43% |
| May, 2030 | $5.9544 | $5.8554 | $5.8462 | +739.24% |
| June, 2030 | $4.6429 | $5.7229 | $5.8769 | +554.39% |
| July, 2030 | $4.8196 | $4.7536 | $4.6996 | +579.30% |
| August, 2030 | $5.251 | $5.0559 | $5.162 | +640.09% |
| September, 2030 | $5.3782 | $5.3983 | $5.3584 | +658.03% |
| October, 2030 | $5.205 | $5.229 | $5.2961 | +633.62% |
| November, 2030 | $5.0104 | $5.0904 | $5.1344 | +606.19% |
| December, 2030 | $4.7718 | $4.8518 | $4.9657 | +572.55% |
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):